Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis

F Sellebjerg, D Hesse, S Limborg, Henrik Lund, H B Søndergaard, M Krakauer, P S Sørensen

26 Citations (Scopus)

Abstract

Treatment with glatiramer acetate (GA) modestly decreases disease activity in multiple sclerosis (MS). The mechanism of action is incompletely understood and differences in the response to treatment between individuals may exist.
Original languageEnglish
JournalMultiple sclerosis
Volume19
Issue number2
Pages (from-to)179-87
Number of pages9
ISSN1352-4585
DOIs
Publication statusPublished - Feb 2013

Keywords

  • Adult
  • Antigen-Presenting Cells
  • Antigens, CD40
  • CD4-Positive T-Lymphocytes
  • Dendritic Cells
  • Female
  • Flow Cytometry
  • HLA-DRB1 Chains
  • Humans
  • Immunosuppressive Agents
  • Lymphocyte Activation
  • Lymphocyte Count
  • Macrophage Activation
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Monocytes
  • Multiple Sclerosis
  • Peptides
  • Recurrence
  • T-Lymphocytes
  • Young Adult

Fingerprint

Dive into the research topics of 'Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis'. Together they form a unique fingerprint.

Cite this